Adagio Medical (Nasdaq:ADGM) announced today that it received FDA breakthrough device designation for its vCLAS cryoablation ...

An individual who has kidney cancer and who is unable to undergo a surgical procedure to remove their malignancy may need to have cryoablation as part of their treatment. Numerous health ...

ICCM reports strong kidney cancer cryoablation study results, showcasing 88.7% recurrence-free rates and reinforcing its position in cryoablation technology. IceCure Medical Ltd. (Nasdaq ...

IceCure Medical ICCM presented interim results from its ICESECRET kidney cancer cryoablation study at the European Association of Urology Conference in Spain. The study reported an 88.7% ...

Halton Healthcare is the first regional hospital to offer renal (kidney) cryoablation, a minimally invasive procedure that targets kidney tumours with precision while minimizing recovery time.

IceCure Medical (ICCM) announced that interim results from the Company’s ICESECRET study of cryoablation for patients with small renal masses who cannot be offered kidney preserving surgery were ...

CAESAREA, Israel - IceCure Medical Ltd. (NASDAQ:ICCM), a developer of minimally invasive cryoablation technology with a market ... and safety of the ProSense® system for treating small renal masses ...

Background: Cryoablation (CRYO) is an alternative to radiofrequency (RF) ablation in the treatment of atrioventricular nodal reentrant tachycardia (AVNRT). This study aims to evaluate the ...